Smokers cling to the ciggies for dear life, knowing it will likely be a much shorter one. An anti-smoking drug released in Australia targets nicotine receptors in the brain, working differently to traditional nicotine replacement therapies. But are we too fixed on a quick fix for addiction? And, the challenge of investigating post-marketing reports that the drug may trigger suicidal thoughts and behaviour in some users. Real side effect of the meds, or part of nicotine withdrawal?

[ Sat, 10 May 2008 00:00:00 +1000 ]

Listen

Download

Listen on your iPhone